Characteristic | ABPA | Atopic asthma | Healthy |
---|---|---|---|
n | 97 | 167 | 280 |
Age (year) (median, IQR) | 61.7 year (54.0–69.5) | 50.1 year (43.8–64.9) | 47.0 year (44.2–50.6) |
% Male | 53.6Â % (52/97) | 41.3Â % | 40.4Â % (113/280) |
Asthma (%) | 88.7Â % (86/97) | 100Â % (167/167) | 0Â % (0/280) |
Lung function tests (n) | 67 | 165 | 255 |
FEV1 % predicted (median, IQR) | 64.0 (51.0–78.0) | 96.0 (78.4–108.2) | 107.5 (99.6–117.2) |
FVC % predicted (median, IQR) | 96.0 (87.5–106.5) | 108.9 (99.0–118.5) | 114.7 (105.6–123.6) |
FEV1/FVC ratio (median, IQR) | 56.0 (47.9–64.0) | 72.0 (63.0–79.0) | 79.0 (75.0–83.0) |
Markers of ABPA | |||
Bronciectasis (%) | 67.0Â % (65/97) | N/A | N/A |
Total serum IgE (kU/L) (median, IQR) (n) | 2250 (1100–4425) (96) | N/A | N/A |
Aspergillus specific IgE (kUA/L) (median, IQR) (n) | 9.7 (3.2–36.0) (62) | N/A | N/A |